Reversal of cardiac dysfunction and subcellular alterations by metoprolol in heart failure due to myocardial infarction

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of Cellular Physiology

• Publication date

  2013-10-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1002/jcp.24373PMID 23553674
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Reversal of Cardiac Remodeling and Subcellular Defects by Prazosin in Heart Failure Due to Myocardial Infarction

  2012cited by this paper
• Cardiac remodeling and subcellular defects in heart failure due to myocardial infarction and aging

  2012influential reference
• Reversal of subcellular remodelling by losartan in heart failure due to myocardial infarction

  2012cited by this paper
• β-AR Blockers Suppresses ER Stress in Cardiac Hypertrophy and Heart Failure

  2011cited by this paper
• β-adrenergic receptor blockade reduces endoplasmic reticulum stress and normalizes calcium handling in a coronary embolization model of heart failure in canines.

  2011cited by this paper
• β-adrenergic blockade attenuates cardiac dysfunction and myofibrillar remodelling in congestive heart failure

  2010influential reference
• Amelioration of Cardiac Remodeling in Congestive Heart Failure by β-Adrenoceptor Blockade is Associated with Depression in Sympathetic Activity

  2010influential reference
• Therapeutic Efficacy of a Combination of a β1-Adrenoreceptor (AR) Blocker and β2-AR Agonist in a Rat Model of Postmyocardial Infarction Dilated Heart Failure Exceeds That of a β1-AR Blocker plus Angiotensin-Converting Enzyme Inhibitor

  2009cited by this paper
• Role of the excessive amounts of circulating catecholamines and glucocorticoids in stress-induced heart disease.

  2009cited by this paper
• Effect of metoprolol and ivabradine on left ventricular remodelling and Ca2+ handling in the post-infarction rat heart.

  2008cited by this paper
• Antiplatelet therapy mitigates cardiac remodeling and dysfunction in congestive heart failure due to myocardial infarction.

  2008cited by this paper
• Subcellular remodelling may induce cardiac dysfunction in congestive heart failure.

  2008cited by this paper
• Carotid body and sympathetic activation in heart failure: a story of sensors and sensitivity.

  2008cited by this paper
• Antiplatelet therapy attenuates subcellular remodelling in congestive heart failure

  2007cited by this paper
• Subcellular Remodeling as a Viable Target for the Treatment of Congestive Heart Failure

  2006influential reference
• Myofibrillar remodeling in cardiac hypertrophy, heart failure and cardiomyopathies.

  2006influential reference
• Modification of sarcolemmal Na+-K+-ATPase and Na+/Ca2+ exchanger expression in heart failure by blockade of renin-angiotensin system.

  2005cited by this paper
• Effect of beta-blockers on cardiac function and calcium handling protein in postinfarction heart failure rats.

  2005cited by this paper
• Effect of β-blockers on cardiac function and calcium handling protein in postinfarction heart failure rats

  2005cited by this paper
• Cardiac remodeling and failure: from molecules to man (Part I).

  2005cited by this paper
• Imidapril treatment improves the attenuated inotropic and intracellular calcium responses to ATP in heart failure due to myocardial infarction

  2005cited by this paper
• Sarcoplasmic reticulum Ca2+ transport and gene expression in congestive heart failure are modified by imidapril treatment.

  2005cited by this paper
• Influence of long-term treatment of imidapril on mortality, cardiac function, and gene expression in congestive heart failure due to myocardial infarction.

  2004cited by this paper
• Modification of myosin protein and gene expression in failing hearts due to myocardial infarction by enalapril or losartan.

  2004influential reference
• Selective beta1-blockade attenuates post-infarct remodelling without improvement in myocardial energy metabolism and function in rats with heart failure.

  2003cited by this paper
• Significance of matrix metalloproteinases in norepinephrine-induced remodelling of rat hearts.

  2003cited by this paper
• Sympathetic nerve activity and neurotransmitter release in humans: translation from pathophysiology into clinical practice.

  2003cited by this paper
• Partial prevention of changes in SR gene expression in congestive heart failure due to myocardial infarction by enalapril or losartan

  2003cited by this paper
• Ca(2+)-handling proteins and heart failure: novel molecular targets?

  2003cited by this paper
• Use of beta-blockers in congestive heart failure

  2003cited by this paper
• Cardiac Remodeling and Failure

  2003cited by this paper
• Selective β1‐blockade attenuates post‐infarct remodelling without improvement in myocardial energy metabolism and function in rats with heart failure

  2003cited by this paper
• Modification of myosin gene expression by imidapril in failing heart due to myocardial infarction.

  2002cited by this paper
• The use of beta-blockers in congestive heart failure.

  2001cited by this paper
• Selective beta(1)-blockade improves cardiac bioenergetics and function and decreases neuroendocrine activation in rats during early postinfarct remodeling.

  2001cited by this paper
• Beta-blockers in congestive heart failure. A Bayesian meta-analysis.

  2001cited by this paper
• Effect of carvedilol on survival in severe chronic heart failure.

  2001cited by this paper
• Nonselective Versus Selective &bgr;-Adrenergic Receptor Blockade in Congestive Heart Failure: Differential Effects on Sympathetic Activity

  2001cited by this paper
• Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial.

  2001cited by this paper
• -Blockers in Congestive Heart Failure: A Bayesian Meta-Analysis

  2001cited by this paper
• Cardiac remodeling--concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling.

  2000cited by this paper
• Sarcoplasmic reticulum Ca(2+)/Calmodulin-dependent protein kinase is altered in heart failure.

  2000cited by this paper
• Effects of impaired Ca2+ homeostasis on contraction in postinfarction myocytes.

  1999cited by this paper
• Alterations in sarcoplasmic reticulum function and gene expression in ischemic-reperfused rat heart.

  1999cited by this paper
• Beta-blockers in heart failure. The 'new wave' of clinical trials.

  1999cited by this paper
• The cellular and physiologic effects of beta blockers in heart failure.

  1999cited by this paper
• beta-Blockers in congestive heart failure.

  1999cited by this paper
• Long-term Beta Adrenoceptor-Mediated Alteration in Contractility and Expression of Phospholamban and Sarcoplasmic Reticulum Ca 11-ATPase in Mammalian Ventricle 1

  1998influential reference
• Comparative efficacy of a DA2/alpha2 agonist and a beta-blocker in reducing adrenergic drive and cardiac fibrosis in an experimental model of left ventricular dysfunction after coronary artery occlusion.

  1998cited by this paper
• Long-term beta adrenoceptor-mediated alteration in contractility and expression of phospholamban and sarcoplasmic reticulum Ca(++)-ATPase in mammalian ventricle.

  1998cited by this paper
• Catecholamines and their blockade in congestive heart failure.

  1998cited by this paper
• Acute Effects of β1-Selective and Nonselective β-Adrenergic Receptor Blockade on Cardiac Sympathetic Activity in Congestive Heart Failure

  1996cited by this paper
• Acute effects of beta 1-selective and nonselective beta-adrenergic receptor blockade on cardiac sympathetic activity in congestive heart failure.

  1996cited by this paper
• [Ca2+]i transients in hypertensive and postinfarction myocytes.

  1995cited by this paper
• Nitrendipine binding in congestive heart failure due to myocardial infarction.

  1990cited by this paper
• Adaptive changes in subcellular calcium transport during catecholamine-induced cardiomyopathy.

  1985cited by this paper
• Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure.

  1984cited by this paper
• Selective desensitization of cardiac beta adrenoceptors by prolonged in vivo infusion of catecholamines in rats.

  1982cited by this paper

• Stellate Ganglia: A Key Therapeutic Target for Malignant Ventricular Arrhythmia in Heart Disease

  2025cites this paper
• Heart rate variability in patients with cardiovascular diseases.

  2025cites this paper
• Research Progress of Traditional Chinese and Western Medicine on Heart Failure after Myocardial Infarction

  2024cites this paper
• Role of Vasoactive Hormone-Induced Signal Transduction in Cardiac Hypertrophy and Heart Failure

  2024cites this paper
• Role of Phospholipase C in Catecholamine-induced Increase in Myocardial Protein Synthesis.

  2022cites this paper
• Cardiometabolic-based chronic disease: adiposity and dysglycemia drivers of heart failure

  2022cites this paper
• Future scope and challenges for congestive heart failure: Moving towards development of pharmacotherapy.

  2022cites this paper
• Stellate Ganglia and Cardiac Sympathetic Overactivation in Heart Failure

  2022cites this paper
• Heart rate variability and the risk of heart failure and its subtypes in post-menopausal women: The Women’s Health Initiative study

  2022cites this paper
• Upregulation of Phospholipase C Gene Expression Due to Norepinephrine-Induced Hypertrophic Response

  2022cites this paper
• Negative inotropic mechanisms of β-cardiotoxin in cardiomyocytes by depression of myofilament ATPase activity without activation of the classical β-adrenergic pathway

  2021cites this paper
• Effects of ivabradine on ventricular electrophysiological remodeling after myocardial infarction in rats

  2020cites this paper
• G protein-coupled receptor kinases as therapeutic targets in the heart

  2019cites this paper
• CA-074Me inhibits Cathepsin-B and alleviates fibrosis after myocardial infarction.

  2019cites this paper
• The infarction zone rather than the noninfarcted remodeling zone overexpresses angiotensin II receptor type 1 and is the main source of ventricular atrial natriuretic peptide.

  2019cites this paper
• Sarcolemmal Alterations in Unloaded Rat Heart after Heterotopic Transplantation

  2018cites this paper
• The crosstalk between autonomic nervous system and blood vessels.

  2018cites this paper
• Activation of β1-adrenoceptors may not be involved in arrhythmogenesis in ischemic heart disease.

  2018cites this paper
• 41 – Sympathetic Innervation and Cardiac Arrhythmias

  2018cites this paper
• Efficacy and Safety of Renal Sympathetic Denervation on Dogs with Pressure Overload-Induced Heart Failure.

  2017cites this paper
• Low-Level Vagus Nerve Stimulation Reverses Cardiac Dysfunction and Subcellular Calcium Handling in Rats With Post-Myocardial Infarction Heart Failure.

  2016cites this paper
• Thrombospondins in the transition from myocardial infarction to heart failure.

  2016cites this paper
• The role of the sympathetic nervous system in sudden cardiac death

  2016cites this paper
• Original Investigation Fibroblast Growth Factor 23 and Sudden Versus Non-sudden Cardiac Death: The Cardiovascular Health Study

  2015cites this paper
• Fibroblast growth factor 23 and sudden versus non-sudden cardiac death: the Cardiovascular Health Study.

  2015cites this paper
• The autonomic nervous system and heart failure.

  2014cites this paper
• Florea and Cohn Autonomic Nervous System and Heart Failure 1817

  2014cites this paper
• Efeitos do metoprolol em modelo experimental de choque

  2014cites this paper
• Prévention de l'insuffisance cardiaque par l'antagonisation du récepteur des minéralocorticoïdes dans un contexte de syndrome métabolique : une étude intégrative du phénome, du transcriptiome et du miRNOme

  2014cites this paper